The Dow® Target 10 Portfolio, December 2024
Series
Ticker Symbol: FAQWGX
Holdings (As of Day of Deposit) |
Ticker |
Company Name |
Initial
Weight |
Price* |
AMGN |
Amgen Inc. |
10% |
$272.58 |
CVX |
Chevron Corporation |
10% |
155.24 |
CSCO |
Cisco Systems, Inc. |
10% |
59.89 |
KO |
The Coca-Cola Company |
10% |
62.53 |
IBM |
International Business Machines Corporation |
10% |
238.04 |
JNJ |
Johnson & Johnson |
10% |
149.31 |
MCD |
McDonald’s Corporation |
10% |
298.98 |
MRK |
Merck & Co., Inc. |
10% |
103.09 |
PG |
The Procter & Gamble Company |
10% |
173.82 |
VZ |
Verizon Communications Inc. |
10% |
42.37 |
*As of the close of business on 12/6/24. Market values are for reference only and are not indicative of your
individual cost basis. Holdings were selected by applying each strategy as described in the prospectus.
Not FDIC Insured Not Bank Guaranteed May Lose Value |
Portfolio Summary |
Initial Offering Date |
12/10/2024 |
Initial Public Offering Price |
$10.00 per Unit |
Portfolio Ending Date |
1/9/2026 |
Historical 12-Month Distribution Rate of Trust Holdings:* |
3.00% |
Historical 12-Month Distribution Per Unit:* |
$0.3003 |
Cash CUSIP |
30339C284 |
Reinvestment CUSIP |
30339C292 |
Fee Accounts Cash CUSIP |
30339C300 |
Fee Accounts Reinvestment CUSIP |
30339C318 |
*There is no guarantee the issuers of the securities included in the trust will declare dividends or distributions
in the future. The historical 12-month distribution per unit and historical 12-month distribution rate of
the securities included in the trust are for illustrative purposes only and are not indicative of the trust’s
distribution or distribution rate. The historical 12-month distribution per unit is based on the weighted
average of the trailing 12-month distributions paid by the securities included in the portfolio. The historical
12-month distribution rate is calculated by dividing the historical 12-month distributions by the trust’s
offering price. The historical 12-month distribution and rate are reduced to account for the effects of fees
and expenses, which will be incurred when investing in a trust. Certain of the issuers may have reduced
their dividends or distributions over the prior 12 months. The distribution per unit and rate paid by the trust
may be higher or lower than the amount shown above due to certain factors that may include, but are not
limited to, a change in the dividends or distributions paid by issuers, actual expenses incurred, or the sale of
securities in the portfolio.
Fee Table (based on a $10 public offering
price per unit) |
|
Standard |
Fee/Wrap |
Deferred Sales Charge |
1.35% |
— |
Creation & Development Fee (C&D Fee) |
0.50% |
0.50% |
Maximum Sales Charge |
1.85% |
0.50% |
|
|
|
Estimated Organization Costs |
0.200% |
0.200% |
Estimated Annual Trust Operating Expenses |
0.172% |
0.172% |
The deferred sales charge will be deducted in three monthly installments commencing 1/17/25. When
the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the
price exceeds $10.00 per unit, you will pay an initial sales charge. The C&D fee is a charge of $0.050 per unit
collected at the end of the initial offering period. If the price you pay exceeds $10.00 per unit, the C&D fee
will be less than 0.50%; if the price you pay is less than $10.00 per unit, the C&D fee will exceed 0.50%.
Estimated organization costs will be deducted from the assets of the trust at the end of the initial offering
period. Estimated organization costs and trust operating expenses are assessed on a fixed dollar amount per
unit basis which, as a percentage of average net assets, will vary over time. Actual expenses may be more or
less than the estimates. Please see “Fee Table” in the trust prospectus for additional information.
You should consider the portfolio's investment objectives, risks, and
charges and expenses carefully before investing. Contact your financial professional
or call First Trust Portfolios L.P. at 1.800.621.1675 to request a prospectus,
which contains this and other information about the portfolio. Read it carefully
before you invest.
Risk Considerations
An investment in this unmanaged unit investment trust should be made
with an understanding of the risks involved with owning common stocks, such as an economic recession and
the possible deterioration of either the financial condition of the issuers of the equity securities or the general
condition of the stock market.
You should be aware that the portfolio is concentrated in stocks in the health care sector which involves
additional risks, including limited diversification. The companies engaged in the health care sector are
subject to fierce competition, high research and development costs, governmental regulations, loss of patent
protection, and changing consumer spending trends. In addition, health crises, such as a pandemic outbreak,
can severely impact the health care industry in particular.
Large capitalization companies may grow at a slower rate than the overall market.
As the use of Internet technology has become more prevalent in the course of business, the trust has become
more susceptible to potential operational risks through breaches in cybersecurity.
Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant groups in the Middle East, have caused and could continue to cause significant market disruptions and volatility
within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance.
A public health crisis, and the ensuing policies enacted by governments and central banks in response,
could cause significant volatility and uncertainty in global financial markets, negatively impacting global
growth prospects.
The value of the securities held by the trust may be subject to steep declines or increased volatility due to
changes in performance or perception of the issuers.
This UIT is a buy and hold strategy and investors should consider their ability to hold the trust until maturity. There may be tax consequences unless units are purchased in an IRA or other qualified plan.
The Dow Jones Industrial Average is a product of S&P Dow Jones Indices LLC or its affiliates (“SPDJI”) and has been licensed for use by First Trust Portfolios L.P. Standard & Poor’s® and S&P® are registered trademarks of Standard
& Poor’s Financial Services LLC (“S&P”); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”); and these trademarks have been licensed for use by SPDJI and sublicensed for certain purposes
by First Trust Portfolios L.P. The Dow® Target 10 Portfolio is not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any representation regarding the
advisability of investing in such product nor do they have any liability for any errors, omissions, or interruptions of the Dow Jones Industrial Average.